Skip to search formSkip to main contentSkip to account menu

Capromab Pendetide

Known as: 7E11-C5.3-GYK-DTPA 
An immunoconjugate of the murine monoclonal antibody, 7E11-C5.3 (Capromab), conjugated to the linker-chelator, glycyl-tyrosyl-(N… 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

CapromabIndicators and ReagentsMonoclonal Antibodies

Narrower (3)

Cytogen 356Indium-111-CYT-356Prostascint

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate…
Review
2011
Review
2011
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.
PURPOSE To compare the diagnostic performance of the synthetic amino acid analog radiotracer anti-1-amino-3-fluorine 18… 
Review
2011
Review
2011
Diagnostic Performance of In-111 Capromab Pendetide SPECT/CT in Localized and Metastatic Prostate Cancer
Purpose: To determine the diagnostic performance of In-111 capromab pendetide single photon emission computed tomography/computed… 
Review
2004
Review
2004
Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer.
OBJECTIVE Our goal was to evaluate the impact of image fusion on the interpretation of indium-111 Prosta-Scint SPECT scans… 
Review
2001
Review
2001
Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
PURPOSE Capromab pendetide (ProstaScint) is an indium In 111 ((111)In)-labeled monoclonal antibody to prostate-specific membrane… 
Highly Cited
1999
Highly Cited
1999
Comparison of clinical staging algorithms and 111Indium‐capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients
The pretherapy prediction of occult lymph node involvement and the avoidance of otherwise futile and potentially morbid… 
Highly Cited
1999
Highly Cited
1999
Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.
Review
1998
Review
1998
Capromab Pendetide
SummaryCapromab pendetide, radiolabelled with indium-111, is a radioimmunoscintigraphic imaging agent used in patients with… 
Highly Cited
1998
Highly Cited
1998
111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group.
PURPOSE Standard diagnostic methods are limited for detecting distant metastases in patients with prostate cancer in whom the… 
1998
1998
Prostate cancer abdominal metastases detected with indium-111 capromab pendetide.
To provide appropriate therapy for prostate cancer, accurate staging of the patient's disease is essential. Determination of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)